Literature DB >> 22841822

Leptin deficiency contributes to the pathogenesis of alcoholic fatty liver disease in mice.

Xiaobing Tan1, Xiuhua Sun, Qiong Li, Yantao Zhao, Wei Zhong, Xinguo Sun, Wei Jia, Craig J McClain, Zhanxiang Zhou.   

Abstract

White adipose tissue (WAT) secretes adipokines, which critically regulate lipid metabolism. The present study investigated the effects of alcohol on adipokines and the mechanistic link between adipokine dysregulation and alcoholic fatty liver disease. Mice were fed alcohol for 2, 4, or 8 weeks to document changes in adipokines over time. Alcohol exposure reduced WAT mass and body weight in association with hepatic lipid accumulation. The plasma adiponectin concentration was increased at 2 weeks, but declined to normal at 4 and 8 weeks. Alcohol exposure suppressed leptin gene expression in WAT and reduced the plasma leptin concentration at all times measured. There is a highly positive correlation between plasma leptin concentration and WAT mass or body weight. To determine whether leptin deficiency mediates alcohol-induced hepatic lipid dyshomeostasis, mice were fed alcohol for 8 weeks with or without leptin administration for the last 2 weeks. Leptin administration normalized the plasma leptin concentration and reversed alcoholic fatty liver. Alcohol-perturbed genes involved in fatty acid β-oxidation, very low-density lipoprotein secretion, and transcriptional regulation were attenuated by leptin. Leptin also normalized alcohol-reduced phosphorylation levels of signal transducer Stat3 and adenosine monophosphate-activated protein kinase. These data demonstrated for the first time that leptin deficiency in association with WAT mass reduction contributes to the pathogenesis of alcoholic fatty liver disease.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22841822      PMCID: PMC3463622          DOI: 10.1016/j.ajpath.2012.06.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.

Authors:  B Campillo; E Sherman; J P Richardet; P N Bories
Journal:  Eur J Clin Nutr       Date:  2001-11       Impact factor: 4.016

2.  Serum leptin levels in post-hepatitis liver cirrhosis.

Authors:  A V Greco; G Mingrone; A Favuzzi; E Capristo; D Gniuli; G Addolorato; A Brunani; F Cavagnin; G Gasbarrini
Journal:  J Hepatol       Date:  2000-07       Impact factor: 25.083

3.  Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha). Alterations in fatty acid homeostasis in HNF1alpha-deficient mice.

Authors:  T E Akiyama; J M Ward; F J Gonzalez
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

4.  Leptin-replacement therapy for lipodystrophy.

Authors:  Elif Arioglu Oral; Vinaya Simha; Elaine Ruiz; Alexa Andewelt; Ahalya Premkumar; Peter Snell; Anthony J Wagner; Alex M DePaoli; Marc L Reitman; Simeon I Taylor; Phillip Gorden; Abhimanyu Garg
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

5.  Metallothionein protection against alcoholic liver injury through inhibition of oxidative stress.

Authors:  Zhanxiang Zhou; Xiuhua Sun; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2002-03

6.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Authors:  Kitt Falk Petersen; Elif Arioglu Oral; Sylvie Dufour; Douglas Befroy; Charlotte Ariyan; Chunli Yu; Gary W Cline; Alex M DePaoli; Simeon I Taylor; Phillip Gorden; Gerald I Shulman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

7.  Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.

Authors:  Mary C Sugden; Karen Bulmer; Geoffrey F Gibbons; Brian L Knight; Mark J Holness
Journal:  Biochem J       Date:  2002-06-01       Impact factor: 3.857

8.  Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

Authors:  Isabelle A Leclercq; Geoffrey C Farrell; Rixt Schriemer; Graham R Robertson
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

9.  The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice.

Authors:  Aimin Xu; Yu Wang; Hussila Keshaw; Lance Yi Xu; Karen S L Lam; Garth J S Cooper
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

10.  Low serum leptin levels and malnutrition in chronic alcohol misusers hospitalized by somatic complications.

Authors:  Francisco Santolaria; Antonia Pérez-Cejas; María-Remedios Alemán; Emilio González-Reimers; Antonio Milena; María-José de la Vega; Antonio Martínez-Riera; María-Angeles Gómez-Rodríguez
Journal:  Alcohol Alcohol       Date:  2003 Jan-Feb       Impact factor: 2.826

View more
  25 in total

1.  Adipose tissue-liver axis in alcoholic liver disease.

Authors:  Zhi-Gang Wang; Xiao-Bing Dou; Zhan-Xiang Zhou; Zhen-Yuan Song
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Sirtuin 1 signaling and alcoholic fatty liver disease.

Authors:  Min You; Alvin Jogasuria; Charles Taylor; Jiashin Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

Review 3.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

4.  Orally administration of Neolentinus lepideus extracts attenuated ethanol induced accumulation of hepatic lipid in mice.

Authors:  Ki Moon Park; Ye Na Park; Oh Yun Kwon; Seung Ho Lee
Journal:  Food Sci Biotechnol       Date:  2018-08-14       Impact factor: 2.391

5.  Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.

Authors:  Wei Zhong; Wenliang Zhang; Qiong Li; Guoxiang Xie; Qian Sun; Xiuhua Sun; Xiaobing Tan; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  J Hepatol       Date:  2014-12-24       Impact factor: 25.083

6.  Dietary Fisetin Supplementation Protects Against Alcohol-Induced Liver Injury in Mice.

Authors:  Qian Sun; Wenliang Zhang; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2016-08-30       Impact factor: 3.455

7.  Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.

Authors:  Wenliang Zhang; Qian Sun; Wei Zhong; Xinguo Sun; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2016-04-08       Impact factor: 3.455

8.  Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.

Authors:  Jason M Correnti; Egle Juskeviciute; Aditi Swarup; Jan B Hoek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

Review 9.  Pathogenesis of Alcoholic Liver Disease.

Authors:  Winston Dunn; Vijay H Shah
Journal:  Clin Liver Dis       Date:  2016-03-28       Impact factor: 6.126

10.  Defect of mitochondrial respiratory chain is a mechanism of ROS overproduction in a rat model of alcoholic liver disease: role of zinc deficiency.

Authors:  Qian Sun; Wei Zhong; Wenliang Zhang; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-11-19       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.